NAS:BIB

PROSHARES TRUST

$ 52.871 -0.1613 ( -0.3%) 11:19 AM EST
PE Ratio:
31.24
PB Ratio:
3.44
Volume:
1.81K
Dividend Yield %:
1.59
Last Holding update 2025-04-24 264 Stocks (68 new)
Value $45.00 Mil Turnover 5 %
Top Holdings: GILD(10.22%) AMGN(9.01%) VRTX(8.48%) REGN(7.22%) AZN(4.24%)
Portfolio Report
Registrant: PROSHARES TRUST
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Performance Chart Fundamental Charts Technical Indicators Gurus Trades Top Holdings Sector Breakdowns Holding History Back to Top

PROSHARES TRUST Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016

PROSHARES TRUST Key Statistics

Name Value
Day's Open ($) 53.03
Day's Range ($) 52.871 - 53.25
Day's Volume 1,807
52-Week Range ($) 33.78 - 69.56
Beta 1.34
3-Year Sharpe Ratio -0.03
3-Year Sortino Ratio -0.05
Volatility 29.38
14-Day RSI 64.57
14-Day ATR ($) 1.60871
20-Day SMA ($) 48.73549

Fundamental Data

Name Value
Market Cap (Mil $) 53.391
Shares Outstanding (Mil) 1.01
PE Ratio 31.24
PE Ratio (10y Range) 16.11 - 31.35
PE Ratio (10y Median) 19.71
PB Ratio 3.44
PB Ratio (10y Range) 1.37 - 5.78
PB Ratio (10y Median) 4.78

Dividend Data

Name Value
Dividends per Share (TTM) ($) 0.851
Dividend Yield % 1.59
Dividend Yield % (10y Range) 0.06 - 2.39
Dividend Yield % (10y Median) 0.7
Next Dividend Payment Date
Dividend Frequency Quarterly

BIB PROSHARES TRUST Fundamental Charts

Historical TTM Price-to-Earnings for BIB PROSHARES TRUST

Historical TTM Price-to-Earnings without NRI for BIB PROSHARES TRUST

Historical Price-to-Book Ratio for BIB PROSHARES TRUST

Historical Dividend Yields for BIB PROSHARES TRUST

PROSHARES TRUST Technical Indicators

Moving Average

Momentum

Gurus Latest Trades with NAS:BIB

No Available Data

NAS:BIB is held by these investors

No Available Data
ProShares Ultra Nasdaq Biotech... Top Holdings of 2025-02-28 View Full List
Ticker
Company
Shares
Value ($1000)
Shares Change %
Weighting %
Trade Impact %
% of Shares outstanding
3M Change %
YTD Change %
Market Cap $Mil
Industry
GILD
Gilead Sciences Inc
40,422
4,620.6
-30.94%
10.220
-3.05%
0.000
+7.44%
+24.33%
140,862.5
Drug Manufacturers
AMGN
Amgen Inc
13,233
4,076.6
-4.45%
9.010
-0.32%
0.000
+11.37%
+20.54%
166,116.2
Drug Manufacturers
VRTX
Vertex Pharmaceuticals Inc
7,994
3,835.4
-14.28%
8.480
-1.14%
0.000
-3.60%
+17.88%
121,906.8
Biotechnology
REGN
Regeneron Pharmaceuticals Inc
4,674
3,265.9
+19.72%
7.220
+1.19%
0.000
-4.49%
-19.48%
61,754.1
Biotechnology
AZN
AstraZeneca PLC
25,191
1,919.8
-22.84%
4.240
-0.92%
0.000
+6.12%
+14.25%
226,194.4
Drug Manufacturers
ALNY
Alnylam Pharmaceuticals Inc
5,582
1,377.4
-22.43%
3.050
-0.74%
0.000
+35.88%
+40.09%
42,983.2
Biotechnology
BIIB
Biogen Inc
6,300
885.1
-22.81%
1.960
-0.55%
0.000
+9.66%
-14.30%
19,203.9
Drug Manufacturers
ARGX
argenx SE
1,394
870.8
-22.51%
1.930
-0.45%
0.000
-3.19%
-5.48%
35,453.1
Biotechnology
SNY
Sanofi SA
13,022
709.3
-20.55%
1.570
-0.30%
0.000
-2.13%
+8.64%
122,136.0
Drug Manufacturers
SMMT
Summit Therapeutics Inc
31,895
659.9
-21.47%
1.460
-0.29%
0.000
-24.28%
+55.73%
20,638.7
Biotechnology

ProShares Ultra Nasdaq Biotechnology's Historical Top Holdings Breakdowns

ProShares Ultra Nasdaq Biotechnology's Top Stock Picks View Full List
Ticker
Company
Date
Action
Impact %
Price Range
Price
Price Change from Avrg%
Comment
Current Shares
Share Change
GILD
Gilead Sciences Inc
2025-02-28
Reduce
Reduce
-3.05%
●
89.14 ($96.3) 114.31
$113.10
17.45%
Reduce -30.94%
40,422
-18,109
REGN
Regeneron Pharmaceuticals Inc
2025-02-28
Add
Add
+1.19%
●
663.86 ($711.04) 788
$572.17
-19.53%
Add 19.72%
4,674
770
VRTX
Vertex Pharmaceuticals Inc
2025-02-28
Reduce
Reduce
-1.14%
●
396.64 ($446.07) 488.44
$474.55
6.38%
Reduce -14.28%
7,994
-1,332
AZN
AstraZeneca PLC
2025-02-28
Reduce
Reduce
-0.92%
●
64.44 ($69.16) 76.21
$73.72
6.59%
Reduce -22.84%
25,191
-7,455
TEM
Tempus AI Inc
2025-02-28
New Buy
New Buy
+0.82%
●
31.83 ($51.59) 89.44
$63.70
23.47%
New holding
6,592
6,592
ALNY
Alnylam Pharmaceuticals Inc
2025-02-28
Reduce
Reduce
-0.74%
●
233.15 ($253.79) 279.19
$329.65
29.89%
Reduce -22.43%
5,582
-1,614
BIIB
Biogen Inc
2025-02-28
Reduce
Reduce
-0.55%
●
133.43 ($147.09) 164.23
$131.48
-10.61%
Reduce -22.81%
6,300
-1,862
ILMN
Illumina Inc
2025-02-28
Reduce
Reduce
-0.55%
●
88.74 ($127.91) 148.53
$106.79
-16.51%
Reduce -23.2%
6,859
-2,072
ARGX
argenx SE
2025-02-28
Reduce
Reduce
-0.45%
●
603.4 ($636.95) 671.75
$581.68
-8.68%
Reduce -22.51%
1,394
-405
MRNA
Moderna Inc
2025-02-28
Reduce
Reduce
-0.38%
●
30.54 ($38.47) 47.53
$34.53
-10.24%
Reduce -22.75%
16,648
-4,902

ProShares Ultra Nasdaq Biotechnology Total Holding History ($B)

To

ProShares Ultra Nasdaq Biotechnology's Asset Allocation

To

ProShares Ultra Nasdaq Biotechnology Past Portfolios

Portfolio Date Number of Stocks New Stocks Total Value ($Mil) Q/Q Turnover

Top Ranked Articles

  • 1

ProShares Ultra Nasdaq Biotechnology's Hypothetical Growth since 2025-02-28

ProShares Ultra Nasdaq Biotechnology's Yearly Returns

Year Portfolio % % Excess Gain %

ProShares Ultra Nasdaq Biotechnology's Holdings Heat Map

Size field:

ProShares Ultra Nasdaq Biotechnology's Holdings Bubble Chart

ProShares Ultra Nasdaq Biotechnology News

  • 1

Discussions on PROSHARES TRUST

User's Avatar
How would you rate this stock? BIB
No discussions yet.
Research Tools
All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board
Product
Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文
Education
Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation
Company
About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program
Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey
Follow Us
download GuruFocus on Apple store download GuruFocus on Google Play
Disclaimers
GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.
© 2004-2025 GuruFocus.com, LLC. All Rights Reserved.